PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
PMV Pharma priced an oversubscribed $50.8 million public offering consisting of common stock, pre-funded warrants, and accompanying warrants. The offering includes units priced at $1.21 for one share of common stock plus one warrant, or $1.20999 for one pre-funded warrant plus one warrant, with warrants exercisable at $1.21.
Key figures
- Deal Value Usd
- 50800000
- Offering Price
- 1.21
- Shares Offered
- 22055000
- Prefunded unit price
- 1.20999
- Prefunded warrants offered
- 19900000
- Accompanying warrants offered
- 41955000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.